packageNelarabine

nelarabine

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Nelarabine is a purine analogue anticancer drug used to treat precursor T-cell lymphoblastic leukemia and lymphoma. It is authorised in the European Union and is used mainly in specialist care for these rare T-cell blood cancers.

Summary written by glm-5.3-flash from Wikidata Q1216264 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:nelarabine
ATC codes:L01BB07
DrugBank:DB01280
PubChem CID:3011155
ChEBI:63612
Wikidata:Q1216264
formula:C11H15N5O5
molar mass:297.271 g/mol (PubChem CID 3011155)
logP:-0.7 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown